Jennifer Amica Cohn, MD
Physical Medicine and Rehabilitation · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 18 years
- Albert Einstein College of Medicine of Yeshiva University, 2008
Offices
2 locations · University of California Sfgh Medical Group · City and County of San Francisco
Looking this up.
Hospitals listed: Laguna Honda Hospital & Rehabilitation Center · Zuckerberg San Francisco General Hosp & Trauma Ctr · 555929. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cohn’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A110257 · Current
Licensed to practise in California · since 2009 · expires 2027-12-31 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Laguna Honda Hospital & Rehabilitation CenterSan Francisco, CAAcute Care Hospital · Government - Local · No emergency departmentPart of San Francisco Health Network, which runs 2 hospitalsNo overall ratingNo measure marked better or worse than the national rate
- Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for Laguna Honda Hospital & Rehabilitation Center
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 28 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 198 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 200 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.58 (0 to 1.87) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Hospital return days for pneumonia patientsUnplanned return visits | 69.4 · 50 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 40 cases | None | Jul 2023 – Jun 2025 |
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.538 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 667 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.76 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.34 (147.34 to 243.34) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 261 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,351 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.5) · 4,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.19 to 0.59) · 4,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.11 to 6.56) · 795 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.33 to 4.38) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0.25 to 17.64) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6 (2.01 to 9.98) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 167 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0.08 to 1.49) · 4,129 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.769 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 227 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 75.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8.3 to 15.1) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.9) · 966 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 88 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,644 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Medicaid work
$702 in 2022
Medicaid paid $702 for 24 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 24 | $702 |
| 2022 | 24 | 1 | 12 | $702 |
| 2021 | 85 | 2 | 15 | $3,484 |
See the largest Medicaid services in earlier years
2021
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 66 | $2,247 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19 | $1,238 |
Drugs they prescribed that Part D paid
$27,883
Pharmacies billed $27,883 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 446) in 2024. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
407 generic and fewer than 11 brand-name prescriptions · $27,883 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 25 | $3,463 | $139 |
| Clonazepam | 14 | $622 | $44 |
| Divalproex Sodium Er | 46 | $342 | $7 |
| Zonisamide | 47 | $271 | $6 |
| Quetiapine Fumarate Er | 47 | $232 | $5 |
See all 10 drugs
| Eliquis | 25 | $3,463 | $139 |
| Clonazepam | 14 | $622 | $44 |
| Divalproex Sodium Er | 46 | $342 | $7 |
| Zonisamide | 47 | $271 | $6 |
| Quetiapine Fumarate Er | 47 | $232 | $5 |
| Metoprolol | 38 | $124 | $3 |
| Baclofen | 19 | $107 | $6 |
| Midodrine | 13 | $100 | $8 |
| Gabapentin | 29 | $93 | $3 |
| Ibuprofen | 11 | $13 | $1 |
Year by year
| 2024 | 446 | None | 0% (0) | None | $27,883 |
| 2023 | 348 | None | None | None | $10,978 |
| 2022 | 626 | None | 0% (0) | 9% | $12,608 |
| 2021 | 731 | None | None | None | $19,614 |
| 2020 | 921 | 14 | 4% (34) | 10% | $18,625 |
| 2019 | 577 | 90 | 5% (30) | None | $21,956 |
| 2018 | 461 | 104 | 8% (37) | None | $32,583 |
| 2017 | 538 | 117 | 8% (42) | None | $29,096 |
| 2016 | 541 | 116 | 7% (39) | None | $28,966 |
| 2015 | 516 | 128 | 9% (46) | None | $28,703 |
| 2014 | 411 | 94 | 11% (45) | None | $26,461 |
| 2013 | 505 | 96 | 9% (47) | None | $30,049 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Eliquis | 17 | $2,207 | $130 |
| Divalproex Sodium Er | 44 | $538 | $12 |
| Midodrine | 12 | $495 | $41 |
| Baclofen | 25 | $323 | $13 |
| Duloxetine | 12 | $317 | $26 |
| Lactulose | 30 | $263 | $9 |
| Dantrolene | 16 | $200 | $12 |
| Levetiracetam | 22 | $153 | $7 |
| Zonisamide | 20 | $134 | $7 |
| Quetiapine Fumarate Er | 17 | $124 | $7 |
| Atorvastatin | 23 | $104 | $5 |
| Gabapentin | 22 | $75 | $3 |
| Benazepril | 16 | $54 | $3 |
| Metoprolol | 18 | $48 | $3 |
2022: 25 drugs
| Eliquis | 47 | $6,215 | $132 |
| Sevelamer Carbonate | 20 | $699 | $35 |
| Baclofen | 38 | $625 | $16 |
| Dantrolene | 26 | $380 | $15 |
| Clonazepam | 15 | $321 | $21 |
| Lactulose | 25 | $275 | $11 |
| Atorvastatin | 55 | $262 | $5 |
| Mirtazapine | 34 | $245 | $7 |
| Valproic Acid | 21 | $220 | $10 |
| Levetiracetam | 39 | $219 | $6 |
| Tizanidine | 17 | $187 | $11 |
| Benazepril | 35 | $163 | $5 |
| Ondansetron Odt | 15 | $155 | $10 |
| Gabapentin | 24 | $118 | $5 |
| Sildenafil Citrate | 14 | $100 | $7 |
| Venlafaxine Hcl Er | 18 | $100 | $6 |
| Hydroxyurea | 12 | $85 | $7 |
| Amlodipine Besylate | 18 | $76 | $4 |
| Zonisamide | 13 | $74 | $6 |
| Furosemide | 17 | $71 | $4 |
| Quetiapine | 16 | $71 | $4 |
| Metoprolol | 27 | $67 | $2 |
| Carvedilol | 18 | $30 | $2 |
| Famotidine | 11 | $26 | $2 |
| Hydrochlorothiazide | 11 | $20 | $2 |
2021: 21 drugs
| Eliquis | 35 | $4,592 | $131 |
| Linzess | 18 | $4,304 | $239 |
| Sevelamer Carbonate | 24 | $1,349 | $56 |
| Oxybutynin Chloride Er | 52 | $431 | $8 |
| Baclofen | 55 | $421 | $8 |
| Atorvastatin | 65 | $330 | $5 |
| Dantrolene | 11 | $321 | $29 |
| Lactulose | 33 | $320 | $10 |
| Heparin | 12 | $279 | $23 |
| Mirtazapine | 36 | $272 | $8 |
| Pantoprazole | 32 | $225 | $7 |
| Venlafaxine Hcl Er | 31 | $172 | $6 |
| Furosemide | 35 | $144 | $4 |
| Amlodipine Besylate | 31 | $130 | $4 |
| Omeprazole | 30 | $130 | $4 |
| Gabapentin | 21 | $117 | $6 |
| Tizanidine | 17 | $107 | $6 |
| Levetiracetam | 13 | $106 | $8 |
| Sertraline | 25 | $104 | $4 |
| Ibuprofen | 14 | $62 | $4 |
| Carvedilol | 30 | $49 | $2 |
2020: 21 drugs
| Xarelto | 39 | $4,305 | $110 |
| Dantrolene | 77 | $2,822 | $37 |
| Eliquis | 20 | $2,377 | $119 |
| Gabapentin | 108 | $828 | $8 |
| Baclofen | 98 | $492 | $5 |
| Mirtazapine | 42 | $435 | $10 |
| Pantoprazole | 64 | $402 | $6 |
| Oxybutynin Chloride Er | 38 | $317 | $8 |
| Atorvastatin | 47 | $283 | $6 |
| Tizanidine | 29 | $201 | $7 |
| Losartan | 28 | $153 | $5 |
| Metoprolol | 20 | $151 | $8 |
| Metformin | 29 | $149 | $5 |
| Glipizide | 28 | $124 | $4 |
| Tramadol | 27 | $115 | $4 |
| Sertraline | 30 | $107 | $4 |
| Ibuprofen | 17 | $89 | $5 |
| Metoprolol | 28 | $75 | $3 |
| Omeprazole | 20 | $72 | $4 |
| Furosemide | 20 | $57 | $3 |
| Famotidine | 13 | $41 | $3 |
2019: 15 drugs
| Enoxaparin | 16 | $1,132 | $71 |
| Gabapentin | 73 | $555 | $8 |
| Baclofen | 36 | $413 | $11 |
| Levetiracetam | 16 | $301 | $19 |
| Metoprolol | 18 | $226 | $13 |
| Atorvastatin | 26 | $220 | $8 |
| Tamsulosin | 13 | $129 | $10 |
| Mirtazapine | 18 | $108 | $6 |
| Hydrocodone-Acetaminophen | 12 | $96 | $8 |
| Amlodipine Besylate | 18 | $88 | $5 |
| Losartan | 13 | $61 | $5 |
| Metformin | 16 | $59 | $4 |
| Sertraline | 15 | $57 | $4 |
| Lisinopril | 13 | $47 | $4 |
| Famotidine | 22 | $47 | $2 |
2018: 5 drugs
| Gabapentin | 25 | $405 | $16 |
| Atorvastatin | 33 | $306 | $9 |
| Levetiracetam | 14 | $183 | $13 |
| Amlodipine Besylate | 16 | $82 | $5 |
| Lisinopril | 13 | $62 | $5 |
2017: 10 drugs
| Atorvastatin | 38 | $365 | $10 |
| Gabapentin | 20 | $326 | $16 |
| Levetiracetam | 20 | $309 | $15 |
| Clopidogrel | 12 | $256 | $21 |
| Hydrocodone-Acetaminophen | 15 | $151 | $10 |
| Tamsulosin | 12 | $148 | $12 |
| Amlodipine Besylate | 30 | $103 | $3 |
| Lisinopril | 16 | $75 | $5 |
| Prednisone | 11 | $50 | $5 |
| Metformin | 13 | $47 | $4 |
2016: 9 drugs
| Atorvastatin | 32 | $327 | $10 |
| Levetiracetam | 20 | $295 | $15 |
| Tamsulosin | 14 | $287 | $21 |
| Gabapentin | 26 | $254 | $10 |
| Hydrocodone-Acetaminophen | 14 | $237 | $17 |
| Amlodipine Besylate | 30 | $99 | $3 |
| Pantoprazole | 12 | $88 | $7 |
| Lisinopril | 19 | $77 | $4 |
| Metoprolol | 12 | $47 | $4 |
2015: 10 drugs
| Xarelto | 14 | $4,498 | $321 |
| Atorvastatin | 36 | $450 | $13 |
| Hydrocodone-Acetaminophen | 22 | $270 | $12 |
| Gabapentin | 23 | $257 | $11 |
| Levothyroxine | 15 | $183 | $12 |
| Metoprolol | 11 | $159 | $14 |
| Amlodipine Besylate | 27 | $126 | $5 |
| Metoprolol | 16 | $112 | $7 |
| Warfarin | 12 | $97 | $8 |
| Lisinopril | 18 | $67 | $4 |
2014: 7 drugs
| Atorvastatin | 22 | $250 | $11 |
| Warfarin | 14 | $155 | $11 |
| Hydrocodone-Acetaminophen | 13 | $145 | $11 |
| Lisinopril | 16 | $95 | $6 |
| Amlodipine Besylate | 21 | $94 | $4 |
| Gabapentin | 11 | $84 | $8 |
| Metoprolol | 14 | $63 | $4 |
2013: 7 drugs
| Atorvastatin | 23 | $541 | $24 |
| Gabapentin | 23 | $366 | $16 |
| Hydrocodone-Acetaminophen | 23 | $284 | $12 |
| Pantoprazole | 15 | $197 | $13 |
| Warfarin | 17 | $157 | $9 |
| Lisinopril | 21 | $105 | $5 |
| Amlodipine Besylate | 14 | $88 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1477866747
- Licence
- CA A110257California A110257: Current · expires 2027-12-31
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2008 · 18 years ago
- Group
- University of California Sfgh Medical Group · City and County of San Francisco
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208100000X (208100000X); Orthopedic surgery (207X00000X)
- Mailing address
- 609 Diamond St, San Francisco, CA, 94114
- NPI first listed
- 2010-07-15
- NPI last updated
- 2025-10-14
- NPI record certified
- 2025-10-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Serra Mall, Palo Alto, CA, 94305 · 2540 23rd St, San Francisco, CA, 94143